TOPLINE: A study reveals nearly a quarter of patients treated with teprotumumab for thyroid eye disease require re-treatment within a year, and older patients are more […]

TOPLINE: In a single-center study, shifting the timing of nutritional insulin from pre- to post-prandial reduced the risk for hypoglycemia without affecting rates of severe hyperglycemia […]

TOPLINE: Researchers identified diverse gut microbial features linked to type 2 diabetes (T2D), suggesting the gut microbiome’s significant role in its pathogenesis and potential for diagnostic […]

TOPLINE: Topical delgocitinib, a pan-Janus kinase inhibitor, was well tolerated and reduced the severity and symptoms of disease in patients with moderate to severe chronic hand […]

TOPLINE: Failure to respond to targeted disease-modifying antirheumatic drugs (tsDMARDs) for psoriatic arthritis occurs at an incident rate of about 0.35 per person-year. METHODOLOGY: An observational […]

TOPLINE: Since 2020, prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for obesity without diabetes has risen, whereas their use for the treatment of type […]

TOPLINE: The regular use of fish oil supplements and high circulating levels of omega-3 polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid (DHA), are associated with a […]

TOPLINE: Acupuncture significantly improved sleep quality in patients with Parkinson’s disease (PD), with benefits lasting up to 8 weeks, results from a randomized clinical trial showed. […]

TOPLINE: Early detection and treatment of rheumatoid arthritis (RA; within 12 weeks of symptom onset) results in lower treatment-related costs over 5 years than later diagnosis. […]